Breaking News Instant updates and real-time market news.

CYTX

Cytori Therapeutics

$0.43

-0.0485 (-10.24%)

09:27
08/09/18
08/09
09:27
08/09/18
09:27

Cytori reports publication of interim pilot data for Cellcordes trial

Cytori Therapeutics announced publication in the peer-reviewed journal, Stem Cell Research and Therapy, of "Autologous adipose-derived stromal vascular fraction and scarred vocal folds: first clinical case report." This report describes preliminary data from the CELLCORDES trial of Cytori Cell Therapy in patients with severe voice dysfunction due to scarring of the vocal fold. The CELLCORDES trial is a fully-enrolled investigator-initiated pilot trial conducted using Cytori Cell Therapy. The trial is being performed by Investigators at the Department of Oto-Rhino-Laryngology and Head and Neck Surgery of Aix-Marseille University and the Cell Therapy Laboratory of La Conception University Hospital, both of Marseille, France. The reported index patient had severe vocal dysfunction persisting for four years following traditional surgery to treat chronic vocal fold lesions. Twelve months after single direct administration with 12 million ADRCs, the patient exhibited improvements in Vocal Handicap Index and other qualitative and quantitative measures of voice quality including: Hirano's GRB scale, Jitter, and vocal range. The authors noted that while the remaining seven patients treated in the CELLCORDES study have yet to complete 12-months of follow-up, no serious adverse events have been reported in any subject and no subject has reported worsening of vocal function. Furthermore, three are exhibiting "very good results (especially on the VHI)".

  • 13

    Aug

CYTX Cytori Therapeutics
$0.43

-0.0485 (-10.24%)

08/11/17
MAXM
08/11/17
NO CHANGE
Target $5
MAXM
Buy
Cytori may still have a window for Habeo approval, says Maxim
Maxim analyst Jason Kolbert said that after speaking at length with Cytori Therapeutics' management his sense is that while the STAR trial missed significance, it wasn't by much in the diffuse patients subgroup, which he believes leaves a path for regulators to still approve its Habeo cell therapy in scleroderma patients. An additional "modestly powered" trial in diffuse patients could set the stage for an approval path, said Kolbert, who added that Azaya is also on track for filing but he does not believe its potential is reflected in Cytori's current "distressed" valuation. Kolbert lowered his price target on Cytori to $5 from $10 but keeps a Buy rating on the stock, which is down nearly 70% since the STAR trial announcement.
03/09/18
RILY
03/09/18
UPGRADE
Target $0.7
RILY
Buy
Cytori Therapeutics upgraded to Buy from Neutral at B. Riley FBR
B. Riley FBR analyst Andrew D'Silva upgraded Cytori Therapeutics to Buy and raised his price target for the shares to 70c from 50c. The company's pipeline has "too many shots on goal to ignore," D'Silva tells investors in a research note.

TODAY'S FREE FLY STORIES

15:05
12/11/18
12/11
15:05
12/11/18
15:05
General news
FOMC Forecast revisions »

FOMC Forecast revisions…

ARWR

Arrowhead

$13.81

0.15 (1.10%)

15:04
12/11/18
12/11
15:04
12/11/18
15:04
Options
Arrowhead options imply 10.5% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

LMT

Lockheed Martin

$293.81

-4.73 (-1.58%)

15:03
12/11/18
12/11
15:03
12/11/18
15:03
Hot Stocks
Lockheed Martin built GPS III satellite encapsulated for December 18 launch »

The U.S. Air Force's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SLB

Schlumberger

$41.37

-0.59 (-1.41%)

15:00
12/11/18
12/11
15:00
12/11/18
15:00
Options
Vote of confidence in Schlumberger as shares fall to 52-week lows »

Vote of confidence in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

  • 18

    Jan

LOB

Live Oak Bancshares

$14.35

-2.3 (-13.81%)

14:56
12/11/18
12/11
14:56
12/11/18
14:56
Downgrade
Live Oak Bancshares rating change  »

Live Oak Bancshares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CORT

Corcept Therapeutics

$15.29

2.31 (17.80%)

14:51
12/11/18
12/11
14:51
12/11/18
14:51
Hot Stocks
Corcept strength attributed to patent issuance »

A spike in shares of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VVV

Valvoline

$20.48

0.33 (1.64%)

14:50
12/11/18
12/11
14:50
12/11/18
14:50
Conference/Events
Valvoline management to meet with Wolfe Research »

Group luncheon to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

VGK

The Vanguard FTSE Europe ETF

$49.43

0.195 (0.40%)

14:50
12/11/18
12/11
14:50
12/11/18
14:50
Options
Put buyer in Vanguard FTSE Europe ETF opens a defensive position »

Put buyer in Vanguard…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AEO

American Eagle

$18.95

-0.57 (-2.92%)

14:49
12/11/18
12/11
14:49
12/11/18
14:49
Options
American Eagle options imply 17.7% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

14:47
12/11/18
12/11
14:47
12/11/18
14:47
Hot Stocks
Breaking Hot Stocks news story  »

Hercules Technology…

TSLA

Tesla

$368.57

3.375 (0.92%)

14:44
12/11/18
12/11
14:44
12/11/18
14:44
Periodicals
Tesla seeks $167 in suit against former employee Tripp, CNBC reports »

Tesla wants over $167M in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

IGC

India Globalization Capital

$0.00

(0.00%)

, CANN

General Cannabis

$0.00

(0.00%)

14:43
12/11/18
12/11
14:43
12/11/18
14:43
Periodicals
NY Gov. Cuomo to introduce plan to legalize recreational marijuana, NY Post says »

New York Governor Andrew…

IGC

India Globalization Capital

$0.00

(0.00%)

CANN

General Cannabis

$0.00

(0.00%)

CGC

Canopy Growth

$31.81

0.82 (2.65%)

MLCPF

MediPharm Labs

$0.00

(0.00%)

CRON

Cronos Group

$12.69

-0.19 (-1.48%)

TLRY

Tilray

$93.40

-3.79 (-3.90%)

CVSI

CV Sciences

$0.00

(0.00%)

CNTTF

CannTrust Holdings

$0.00

(0.00%)

ACB

Aurora Cannabis

$5.88

0.17 (2.98%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 12

    Dec

QSR

Restaurant Brands

$52.82

-0.97 (-1.80%)

14:40
12/11/18
12/11
14:40
12/11/18
14:40
Options
Puts on the menu at Restaurant Brands International »

Puts on the menu at…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

CGC

Canopy Growth

$31.78

0.79 (2.55%)

14:39
12/11/18
12/11
14:39
12/11/18
14:39
Technical Analysis
Technical Take: Canopy Growth pops in later afternoon trading »

The shares have spiked in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

CSCO

Cisco

$46.72

-0.14 (-0.30%)

, INTC

Intel

$47.16

-0.05 (-0.11%)

14:31
12/11/18
12/11
14:31
12/11/18
14:31
Periodicals
Cisco in talks to acquire chip company Luxtera, Bloomberg reports »

Cisco Systems (CSCO) is…

CSCO

Cisco

$46.72

-0.14 (-0.30%)

INTC

Intel

$47.16

-0.05 (-0.11%)

AVGO

Broadcom

$244.97

5.76 (2.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 11

    Dec

  • 12

    Dec

  • 10

    Jan

DUK

Duke Energy

$90.52

-0.03 (-0.03%)

14:18
12/11/18
12/11
14:18
12/11/18
14:18
Hot Stocks
Duke says 45,000 customers in Carolinas remain without power after storm »

Duke Energy said it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

14:17
12/11/18
12/11
14:17
12/11/18
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LBTYA

Liberty Global

$22.82

-0.84 (-3.55%)

, VOD

Vodafone

$20.08

-0.055 (-0.27%)

14:16
12/11/18
12/11
14:16
12/11/18
14:16
Hot Stocks
Liberty Global says 'always anticipated' second phase review from EC »

The European Commission…

LBTYA

Liberty Global

$22.82

-0.84 (-3.55%)

VOD

Vodafone

$20.08

-0.055 (-0.27%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

14:16
12/11/18
12/11
14:16
12/11/18
14:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVDA

Nvidia

$147.66

-4.32 (-2.84%)

, SFTBF

SoftBank

$0.00

(0.00%)

14:13
12/11/18
12/11
14:13
12/11/18
14:13
Hot Stocks
Nvidia near lows as SoftBank said to plan sale of stake »

Shares of Nvidia (NVDA)…

NVDA

Nvidia

$147.66

-4.32 (-2.84%)

SFTBF

SoftBank

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 06

    Jan

NVDA

Nvidia

$147.60

-4.38 (-2.88%)

, SFTBF

SoftBank

$0.00

(0.00%)

14:11
12/11/18
12/11
14:11
12/11/18
14:11
Periodicals
Breaking Periodicals news story on Nvidia, SoftBank »

SoftBank planning sale of…

NVDA

Nvidia

$147.60

-4.38 (-2.88%)

SFTBF

SoftBank

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 06

    Jan

CSCO

Cisco

$46.81

-0.05 (-0.11%)

14:10
12/11/18
12/11
14:10
12/11/18
14:10
Periodicals
Breaking Periodicals news story on Cisco »

Cisco in talks to acquire…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 12

    Dec

  • 10

    Jan

CORT

Corcept Therapeutics

$12.66

-0.32 (-2.47%)

14:10
12/11/18
12/11
14:10
12/11/18
14:10
Hot Stocks
Corcept Therapeutics spikes in afternoon trading, jump 16% »

Corcept is up $2.04, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APTV

Aptiv

$66.34

1.01 (1.55%)

14:10
12/11/18
12/11
14:10
12/11/18
14:10
Hot Stocks
Aptiv CEO Kevin Clark purchases 11,310 shares of company stock »

Aptiv CEO Kevin Clark…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FSLR

First Solar

$42.08

-1.14 (-2.64%)

14:10
12/11/18
12/11
14:10
12/11/18
14:10
Options
Second day of short-term put buying in First Solar ahead of a company event »

Second day of short-term…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.